Skip to main content
Log in

Amentoflavone protects against psoriasis-like skin lesion through suppression of NF-κB-mediated inflammation and keratinocyte proliferation

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Psoriasis is a one of the most common chronic skin diseases, which affects 0.6–4.8 % of the general population. Amentoflavone (AMF) belongs to the biflavonoid class of flavonoids, possessing various biological effects, such as anti-inflammatory, antioxidant, and anti-apoptotic effects. In the present study, we aimed to investigate the effect of AMF on psoriasis in imiquimod (IMQ) psoriasis-like lesions in mice and keratinocyte proliferation in HaCaT cells. We showed that AMF reduced skinfold thickening, and improved erythema and scaling scores and histological lesions in IMQ-treated mice. AMF exerted potent anti-inflammatory effect via influencing a variety of proinflammatory cytokines, including tumor necrosis factor α, interleukin (IL)-17A, IL-22, and IL-23 in local skin lesions and the whole body. In M5 (a cocktail of cytokines)-treated HaCaT cells, AMF significantly inhibited cell proliferation, promoted apoptosis, and inhibited the increase of expression of cyclin D1, cyclin E, IL-17A, and IL-22. In addition, AMF inhibited the upregulation of p65 NF-κB under psoriatic condition. Moreover, overexpression of p65 NF-κB significantly suppressed the effect of AMF on keratinocyte proliferation, apoptosis, and expression of cyclin D1, cyclin E, IL-17A, and IL-22. These results demonstrated that suppression of NF-κB was involved in AMF-resulted anti-proliferative, apoptosis-promoting, anti-inflammatory effects in keratinocytes. The data demonstrate that AMF may serve as potential therapeutic option for patients with psoriasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Naldi L (2004) Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy 3:121–128

    Article  CAS  PubMed  Google Scholar 

  2. Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N Engl J Med 361:496–509

    Article  CAS  PubMed  Google Scholar 

  3. Raychaudhuri SP, Farber EM (2001) The prevalence of psoriasis in the world. J Eur Acad Dermatol Venereol 15:16–17

    Article  CAS  PubMed  Google Scholar 

  4. Harden JL, Krueger JG, Bowcock AM (2015) The immunogenetics of Psoriasis: a comprehensive review. J Autoimmun 64:66–73

    Article  CAS  PubMed  Google Scholar 

  5. Lønnberg AS, Skov L, Duffy DL, Skytthe A, Kyvik KO, Pedersen OB, Thomsen SF (2015) Genetic factors explain variation in the age at onset of psoriasis: a population-based twin study. Acta Derm Venereol. doi:10.2340/00015555-2171

    Google Scholar 

  6. Park BS, Youn JI (1998) Factors influencing psoriasis: an analysis based upon the extent of involvement and clinical type. J Dermatol 25:97–102

    Article  CAS  PubMed  Google Scholar 

  7. Perera GK, Di Meglio P, Nestle FO (2012) Psoriasis. Annu Rev Pathol 7:385–422

    Article  CAS  PubMed  Google Scholar 

  8. Gottlieb AB, Armstrong AW (2013) Psoriasis outcome measures: a report from the GRAPPA 2012 annual meeting. J Rheumatol 40:1428–1433

    Article  PubMed  Google Scholar 

  9. Cohen AD, Sherf M, Vidavsky L, Vardy DA, Shapiro J, Meyerovitch J (2008) Association between psoriasis and the metabolic syndrome. A cross-sectional study. Dermatology 216:152–155

    Article  CAS  PubMed  Google Scholar 

  10. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM (2006) Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 55:829–835

    Article  PubMed  Google Scholar 

  11. Kastelan M, Prpic-Massari L, Brajac I (2009) Apoptosis in psoriasis. Acta Dermatovenerol Croat 17:182–186

    CAS  PubMed  Google Scholar 

  12. Weatherhead SC, Farr PM, Jamieson D, Hallinan JS, Lloyd JJ, Wipat A, Reynolds NJ (2011) Keratinocyte apoptosis in epidermal remodeling and clearance of psoriasis induced by UV radiation. J Invest Dermatol 131:1916–1926

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Tiberio R, Bozzo C, Pertusi G, Graziola F, Gattoni M, Griffanti P, Boggio P, Colombo E, Leigheb G (2009) Calcipotriol induces apoptosis in psoriatic keratinocytes. Clin Exp Dermatol 34:e972–e974

    Article  CAS  PubMed  Google Scholar 

  14. Grine L, Dejager L, Libert C, Vandenbroucke RE (2015) An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17. Cytokine Growth Factor Rev 26:25–33

    Article  CAS  PubMed  Google Scholar 

  15. Wagner EF, Schonthaler HB, Guinea-Viniegra J, Tschachler E (2010) Psoriasis: what we have learned from mouse models. Nat Rev Rheumatol 6:704–714

    Article  CAS  PubMed  Google Scholar 

  16. Schon MP, Boehncke WH (2005) Psoriasis. N Engl J Med 352:1899–1912

    Article  CAS  PubMed  Google Scholar 

  17. Huang N, Rizshsky L, Hauck CC, Nikolau BJ, Murphy PA, Birt DF (2012) The inhibition of lipopolysaccharide-induced macrophage inflammation by 4 compounds in Hypericum perforatum extract is partially dependent on the activation of SOCS3. Phytochemistry 76:106–116

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Tsai SC, Liang YH, Chiang JH, Liu FC, Lin WH, Chang SJ, Lin WY, Wu CH, Weng JR (2012) Anti-inflammatory effects of Calophyllum inophyllum L. in RAW264.7 cells. Oncol Rep 28:1096–1102

    CAS  PubMed  Google Scholar 

  19. Woo ER, Lee JY, Cho IJ, Kim SG, Kang KW (2005) Amentoflavone inhibits the induction of nitric oxide synthase by inhibiting NF-kappaB activation in macrophages. Pharmacol Res 51:539–546

    Article  CAS  PubMed  Google Scholar 

  20. Banerjee T, Valacchi G, Ziboh VA, van der Vliet A (2002) Inhibition of TNFalpha-induced cyclooxygenase-2 expression by amentoflavone through suppression of NF-kappaB activation in A549 cells. Mol Cell Biochem 238:105–110

    Article  CAS  PubMed  Google Scholar 

  21. Nadeem A, Al-Harbi NO, Al-Harbi MM, El-Sherbeeny AM, Ahmad SF, Siddiqui N, Ansari MA, Zoheir KM, Attia SM, Al-Hosaini KA, Al-Sharary SD (2015) Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation. Pharmacol Res 99:248–257

    Article  CAS  PubMed  Google Scholar 

  22. Zhao Y, Sun J, Dou W, Hu JH (2015) Curcumin inhibits proliferation of interleukin-22-treated HaCaT cells. Int J Clin Exp Med 8:9580–9584

    PubMed Central  PubMed  Google Scholar 

  23. Kjaer TN, Thorsen K, Jessen N, Stenderup K, Pedersen SB (2015) Resveratrol ameliorates imiquimod-induced psoriasis-like skin inflammation in mice. PLoS One 10:e126599

    Article  Google Scholar 

  24. Nograles KE, Davidovici B, Krueger JG (2010) New insights in the immunologic basis of psoriasis. Semin Cutan Med Surg 29:3–9

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Guruvayoorappan C, Kuttan G (2008) Inhibition of tumor specific angiogenesis by amentoflavone. Biochemistry (Mosc) 73:209–218

    Article  CAS  Google Scholar 

  26. Kang DG, Yin MH, Oh H, Lee DH, Lee HS (2004) Vasorelaxation by amentoflavone isolated from Selaginella tamariscina. Planta Med 70:718–722

    Article  CAS  PubMed  Google Scholar 

  27. Lin YM, Anderson H, Flavin MT, Pai YH, Mata-Greenwood E, Pengsuparp T, Pezzuto JM, Schinazi RF, Hughes SH, Chen FC (1997) In vitro anti-HIV activity of biflavonoids isolated from Rhus succedanea and Garcinia multiflora. J Nat Prod 60:884–888

    Article  CAS  PubMed  Google Scholar 

  28. Mora A, Paya M, Rios JL, Alcaraz MJ (1990) Structure-activity relationships of polymethoxyflavones and other flavonoids as inhibitors of non-enzymic lipid peroxidation. Biochem Pharmacol 40:793–797

    Article  CAS  PubMed  Google Scholar 

  29. Zhang Z, Sun T, Niu JG, He ZQ, Liu Y, Wang F (2015) Amentoflavone protects hippocampal neurons: anti-inflammatory, antioxidative, and antiapoptotic effects. Neural Regen Res 10:1125–1133

    Article  PubMed Central  PubMed  Google Scholar 

  30. van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD, Cornelissen F, Mus AM, Florencia E, Prens EP, Lubberts E (2009) Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol 182:5836–5845

    Article  PubMed  Google Scholar 

  31. Van Belle AB, de Heusch M, Lemaire MM, Hendrickx E, Warnier G, Dunussi-Joannopoulos K, Fouser LA, Renauld JC, Dumoutier L (2012) IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice. J Immunol 188:462–469

    Article  PubMed  Google Scholar 

  32. Liu Y, Yang G, Zhang J, Xing K, Dai L, Cheng L, Liu J, Deng J, Shi G, Li C, Su X, Zhang S, Yang Y, Li J, Yu D, Xiang R, Wei Y, Deng H (2015) Anti-TNF-alpha monoclonal antibody reverses psoriasis through dual inhibition of inflammation and angiogenesis. Int Immunopharmacol 28:731–743

    Article  CAS  PubMed  Google Scholar 

  33. Sakthivel KM, Guruvayoorappan C (2013) Amentoflavone inhibits iNOS, COX-2 expression and modulates cytokine profile, NF-kappaB signal transduction pathways in rats with ulcerative colitis. Int Immunopharmacol 17:907–916

    Article  CAS  PubMed  Google Scholar 

  34. Lee JS, Lee MS, Oh WK, Sul JY (2009) Fatty acid synthase inhibition by amentoflavone induces apoptosis and antiproliferation in human breast cancer cells. Biol Pharm Bull 32:1427–1432

    Article  CAS  PubMed  Google Scholar 

  35. Lee SJ, Choi JH, Son KH, Chang HW, Kang SS, Kim HP (1995) Suppression of mouse lymphocyte proliferation in vitro by naturally-occurring biflavonoids. Life Sci 57:551–558

    Article  CAS  PubMed  Google Scholar 

  36. Siveen KS, Kuttan G (2011) Effect of amentoflavone, a phenolic component from Biophytum sensitivum, on cell cycling and apoptosis of B16F-10 melanoma cells. J Environ Pathol Toxicol Oncol 30:301–309

    Article  CAS  PubMed  Google Scholar 

  37. Lee S, Kim H, Kang JW, Kim JH, Lee DH, Kim MS, Yang Y, Woo ER, Kim YM, Hong J, Yoon DY (2011) The biflavonoid amentoflavone induces apoptosis via suppressing E7 expression, cell cycle arrest at sub-G(1) phase, and mitochondria-emanated intrinsic pathways in human cervical cancer cells. J Med Food 14:808–816

    Article  CAS  PubMed  Google Scholar 

  38. Yan S, Xu Z, Lou F, Zhang L, Ke F, Bai J, Liu Z, Liu J, Wang H, Zhu H, Sun Y, Cai W, Gao Y, Su B, Li Q, Yang X, Yu J, Lai Y, Yu XZ, Zheng Y, Shen N, Chin YE, Wang H (2015) NF-kappaB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis. Nat Commun 6:7652

    Article  PubMed Central  PubMed  Google Scholar 

  39. Hong KK, Gwak MJ, Song J, Kim NI (2015) NF-kappaB pathway activation and PTEN downregulation in psoriasis. Br J Dermatol. doi:10.1111/bjd.14106

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jia Huo.

Ethics declarations

Conflict of interest

The authors declare that there have no conflict of interest to declare.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 46 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

An, J., Li, Z., Dong, Y. et al. Amentoflavone protects against psoriasis-like skin lesion through suppression of NF-κB-mediated inflammation and keratinocyte proliferation. Mol Cell Biochem 413, 87–95 (2016). https://doi.org/10.1007/s11010-015-2641-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-015-2641-6

Keywords

Navigation